0001237899-12-000051.txt : 20120502
0001237899-12-000051.hdr.sgml : 20120502
20120502115626
ACCESSION NUMBER: 0001237899-12-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120430
FILED AS OF DATE: 20120502
DATE AS OF CHANGE: 20120502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aberman Michael S
CENTRAL INDEX KEY: 0001487767
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 12803551
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0305
4
2012-04-30
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001487767
Aberman Michael S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
VP Strategy and Investor Relat
Common Stock
2012-04-30
4
M
0
12500.0
24.0
A
22500.0
D
Common Stock
2012-04-30
4
F
0
2168.0
138.31
D
20332.0
D
Common Stock
2012-04-30
4
F
0
4170.0
138.31
D
16162.0
D
Common Stock
2012-05-01
4
S
0
3862.0
134.52
D
12300.0
D
Common Stock
2012-05-01
4
S
0
2300.0
135.29
D
10000.0
D
Common Stock
287.0
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
24.0
2012-04-30
4
M
0
12500.0
D
2020-03-22
Common Stock
12500.0
58336.0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 3,862 shares of Company stock on May 1, 2012 at prices ranging from $134.01 to $134.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2012 at each separate price.
Represents volume-weighted average price of sales of 2,300 shares of Company stock on May 1, 2012 at prices ranging from $135.03 to $135.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2012 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests over five years, commencing one year after the date of grant. 12,500 options vest on the first anniversary, 25,000 options vest on the second anniversary, 25,000 options vest on the third anniversary, 25,000 options vest on the fourth anniversary, and 12,500 options vest on the fifth anniversary of the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Michael S. Aberman
2012-05-02